Firering Strategic Minerals: From explorer to producer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: mol42, 14 May 2024 20:30
Last post: martinu, Today 14:47
Fair points. And not long to wait for FY figures. Probably next Weds. And likely more underwhelming numbers.
Stephen really has achieved very little, relative to the package he has drawn, in the past couple of years. And that is being generous, IMO.
You can accept these things take time, but this is hardly a business in the first few years of existence.
We should be turning a profit by now and free from the need for any further cash raises.
Marketing and business development has been disappointing for years too. Which he ultimately has to take responsibility for.
A new six month low print too, in a share with very little trading volume, underpinning this failure to generate interest in the company from the wider investment community. Another failure on SOH, as far as I am concerned.
Whenever the next update comes, will show us whether we are still a jam tomorrow lifestyle outfit, or finally starting to turn into a serious business.
The SP suggests a sentiment very much supporting the former, but I am sure we would all be delighted if it turns out to be the latter.
Ah well. The sun is shining, so might as well make the most of it. GLA.
This was SOH's response from a few months ago on the subject. No idea how many people it reached.
https://optibiotix.com/injectable-weight-loss-drugs-are-they-the-holy-grail/?utm_source=linkedin&utm_medium=social&utm_campaign&utm_content=ap_zggsww6dh6
Good point Mol. I'd forgotten all about that.
Having those in city centre Boots where a big part of their business seems to be food on the move, would be a good thing.......if it happens.
Maybe our business development manager of 4 years 3 months could follow up on our rns of 22 sep 2023
mol
Last post: lordloadsoflolly, 17 Jun 2024 11:59
Andrew7 - the only "celeb" I can think of who might prove a decent fit is Steven Bartlett. IMHO, most so-called celebrities & influencers are nothing much more than vacuous airheads.
Problem is, I suspect you'd get a lot lower conversion than 1%. And Steven Bartlett's fee would probably wipe out all the profit. And some.
We have got to get the share price up somehow😀
I liked the logical extension of buying their own products on amazon as well.
Regarding the shadows opti has several great scienfically reviewed products yet barely anybody has heard of us. Would it not make sense too get some form of celebrity endorsement. Perhaps sponsor a well known YouTubers channel for one episode. Some of these guys can get several hundred thousand views per podcast.
If the right celeb was approached I.e one that fits Optis target market then that could make quite a difference in the bottom line. Say said Celeb gets 300,000 views on podcast if even 1% of the viewers go and try Optibiotix that's 3000 people who might spend £20 a piece. There's £60,000. If 1/3 of those buy on a recurring basis that might be £10 a month so 1000*10*12 =£120,000 a year. Added to your 60 grand gives £180,000. Then as people continue watching the podcast more clients would roll in. Share price improves, Opti gets more exposure in investor publications possibly interest from institutional investors.
This from Opti re eBay on LinkedIn
https://www.linkedin.com/company/optibiotix-health-plc?trk=organization_guest_main-feed-card_feed-actor-name
I like your thinking Andrew.
Maybe Opti should buy from Amazon as a way of pushing them up the algorithms. They could then resell the same stock from the website.
Boom.
On a slightly less frivolous note, it is a tad frustrating that we have this great product which is hiding in the shadows.
Can’t trade opti on spread but can Pbx, how does that work?
Started: elrico, 16 Jun 2024 18:41
Last post: KingKevin, 17 Jun 2024 10:10
I bought some they are delicious.
Just ordered some more with the 40% discount.
Sorry, I forgot to post the offer here.
Discount code: IND40
40% off the Indulgent Bar only - One-time use per customer.
For your information, the RRP of bars is £24.99. With a 40% discount, the charge is £15. There is a standard delivery charge of £4.99. However, delivery is FREE for orders over £50.
https://optibiotix.online/collections/snack-smart/products/snacksmart-indulgence-bar?utm_source=substack&utm_medium=email
Started: mol42, 14 Jun 2024 18:04
Last post: martinu, 14 Jun 2024 21:30
And regarding potential sale of Seed. I have no idea where PBX (LPldl) would stand if this went ahead.
Thanks mol for the summary. Very tricky to est full year revenue. Given confirmed v invoiced in H1. If PBX got between £1.75m-£2m revs full year, I'd be pretty satisfied. But that H1 discrepancy (conf v in) is very big. And as you say, we can expect a jump in admin costs through appt of new staff. All of whom seem to be heads of something so on a generous salary. Though some not in place for full year. But nevertheless, loss could easily increase because of this.
I was referring to the overall financial performance as stated by the BOD - not turnover
and therefore the bottom line - a perhaps even bigger loss
mol
An 83% increase in H1 if repeated in H2 and full year would see 2023 revenue approx £2.3m.
I'd say that was satisfactory. Anything short of £2m would be disappointing imo.
Doesn't depend on my definition at all
mol
Started: mol42, 12 Jun 2024 17:54
Last post: FriedmanSowell, 13 Jun 2024 09:29
This time next year Rodney.
Thanks for posting. One day... 🎶
Capital Markets Day 3rd June 2024
Taste Texture Health
https://www.dsm-firmenich.com/content/dam/dsm-firmenich/corporate/documents/results-center/capital-markets-day-2024/capital-markets-day-tth-web-version.pdf
sugar reduction prominent throughout
we continue to live in hope that this year will not become next year as so many have in the past
mol
Started: mol42, 7 May 2024 17:05
Last post: mol42, 12 Jun 2024 16:58
Whilst we wait audited financial statements
just a bit more recent info re this collaboration which i also believe provides useful info in general for anyone new here
https://www.microbiometimes.com/a-synbiotic-step-forward-dr-lucien-harthoorn-talks-synbiotic-science-and-clasados-collaboration-with-probi/
https://clasado.com/synbiotics-with-bimuno-gos/
albeit clasado ltd is technically insolvent (-£32m) and requires the funding of its owner clasado biosciences ltd a jersey based company - in turn owned by a company in Liechtenstein
Stephen did like to mention Probi - mind don't recall him doing so recently - wouldn't have anything to do with Per, Fred and Steven now at clasado would it?
a pity we didn't have a collaboration with probi prior to a number of ex-opti joining same
suppose though Stephen knows best
we will see (if we haven't already)
bw all
mol
Per's wife Laura still notes herself as a senior consultant to us on her linkedin profile
Consultant
Rehne consulting
Feb 2019 - Present 5 years 4 months
bishops stortford
OPTIBIOTIX HEALTH PLC
Senior Consultant
OPTIBIOTIX HEALTH PLC
Jan 2018 - Present 6 years 5 months
https://find-and-update.company-information.service.gov.uk/company/11704034
mol
Oops meant to also post
https://www.probi.com/annual-report/en/
mol
Stephen has mentioned Probi a number of times over the years so I thought I would just do a bit of doodling
and their relationship with clasado biosciences seems to be going from strength to strength
https://www.probi.com/search/?query=clasado
I recognise at least three of the team at Clasado
https://clasado.com/corporate/
just a bit of info
mol
Has anyone actually found these gummies? I have looked and can't find any trace. Are they under another 3rd party brand?
Are we supplying a white label product?
Any actual proof of existence appreciated. TIA.
Thank you
The recent IMC mentioned 20k / month as a projection
For completeness 1 nov 2023
We have seen an increase in both the number of Apollo stores selling products in India and sales increase month on month with September 2023 sales up 624% from launch in September 2022 and the highest monthly sales to date. Apollo have reported an 87% repeat purchase rate with 27% new customers coming into their stores to buy GoFigure products. We are experiencing similar sales growth with Nahdi Medical pharmacies in Saudi Arabia with a 219% increase in sales since launch in March 2023 with September 2023 again the highest monthly sales to date.
mol
Just thought I would follow up on this
https://www.optibiotix-ir.com/content/news/archive/2021/15-12-21
which as we know took to Oct 22 and a launch in 2023
https://www.optibiotix-ir.com/content/news/archive/2022/241022
and in sep 2023
improved sales performance in H1 2023 by Apollo Pharmacies (up 500%) in India and Nahdi Medical (up 30%) in Saudi Arabia following more active account management. These increased sales are not reflected in H1 but impact on restocking requirements in H2 2023
https://www.nahdionline.com/en/healthy-food/meal-replacement?manufacturer=Gofigure
https://www.nahdionline.com/en/?q=slimbiome
think we can assume that this agreement isn't going to add a lot to our revenue - 2023 audited results coming soon
and as a reminder
https://gofigurediet.com/shop-saudi-arabia-coming-soon/
https://gofigurediet.com/shop-india/
and the shots at least do appear at
https://www.apollopharmacy.in/otc/gofigure-shot-mixed-flav-sachet-30g-2-s
albeit not that easy to find mind that was probably because i blocked my location
mol
Started: AquaeSulis01, 8 Jun 2024 10:47
Last post: AquaeSulis01, 8 Jun 2024 10:47
Started: Masterbaker, 4 Jun 2024 10:28
Last post: Masterbaker, 4 Jun 2024 11:02
It will be on iplayer if you want to see it for yourself, maybe you will come to a different opinion to mine.
No I'm not saying it's sbtx. Pro's or pre's I think many or even most do not know the difference, what I am saying is it's by association which is not good.
MB, I think the point you are trying to make is valid. But you might be mixing up your pro-s and pre-s, and indeed skins. Are you referring to SlimBiome? Which seems to be improving sales, but in UK particularly, seems not very widely known.
This morning BBC1, featured an item on losing weight (15 lb a week):-/ using probiotics, usual doctors rec's, we all know it's false, and they used the typical advertising style. This sort of thing does nothing to help sbtx and sbtx needs to be on their toes and find better ways of marketing.
Started: martinu, 3 Jun 2024 17:11
Last post: FriedmanSowell, 3 Jun 2024 21:21
Thanks for that Mart. I hadn’t seen it. I like that news. Hopefully we earned enough to pay for his trip out there to take the photos.
Not sure if this market has been mentioned much.
https://www.linkedin.com/feed/update/ugcPost:7185556318441668608?trk=feed_main-feed-card_social-actions-comments
You can all decide who knows where we're going and where we've been
Well, we know where we're goin'
But we don't know where we've been
And we know what we're knowin'
But we can't say what we've seen
And we're not little children
And we know what we want
And the future is certain
Give us time to work it out
We're on a road to nowhere
Come on inside
Takin' that ride to nowhere
We'll take that ride
I'm feelin' okay this mornin'
And you know
We're on a road to paradise
Here we go, here we go
But it's growing day by day
And it's all right, baby it's all right
Would you like to come along?
And you could help me sing this song
And it's all right, baby it's all right
They can tell you what to do
But they'll make a fool of you
tick tock
mol
Https://www.youtube.com/watch?v=LQiOA7euaYA
let's hope not
mind
lets keep the family salaries going boys
mol
There have been other prior rnses but i'll just remind this bb re the most recent
https://www.optibiotix-ir.com/content/news/archive/2023/231023
https://www.optibiotix-ir.com/content/news/archive/2024/130324
he mentioned tata in his most recent presentation - albeit nowt to do with the rns of 23 oct which perhaps is now going nowhere?
mol
Twas this one
https://www.colonial.com.uy/productos/categoria/yogur/con-probi%C3%B3ticos
and still on home page
https://www.colonial.com.uy/
mol
mol
mol
Aquae. Thanks for sharing. We did have a tie up with a Uruguaian company for dairy. Can't remember for which product. Was it LPldl? And of course, if SweetBiotix gains traction, we are hopefully on a big price winner. (Appropriate emoji)
Clean label product demand gaining momentum; sweetener paragraph makes sweetbiotix a perfect fit.
https://www.dairyreporter.com/Article/2024/04/25/clean-label-dairy-and-consumer-attitudes
New opti?
lol
more or less same as old /existing opti imo
mol
I don't think it includes the recharge as revenue for 2022 didn't
albeit this note isn't that clear - note 13
During the period 1 January 2022 to 31 March 2022 Optibiotix Health PLC loaned Probiotix Limited £150,000, to finance working capital costs in the period up to the listing of Probiotix Health Group plc. During the year £203,835 was repaid. The balance due to Probiotix Limited at 31 December 2022 of £10,137 (2021 owing: £53,835) was repaid post year end. There was no interest charged during the year.
During the year Optibiotix Health PLC loaned Optibiotix Limited £1,220,000 to finance working capital costs. Optibiotix Limited recharged Optibiotix Health PLC £373,426 for salary costs. The balance at the year end of £846,574 (2021, £931,903) was cancelled.
There was no interest charged during the year. This does not impact on the consolidated Group accounts.
During the year Optibiotix Limited recharged Probiotix Health Plc £23,139 for directors’ fees. Optibiotix Limited received a recharge from Probiotix Health Plc for admin costs of £148. The balance at the year end of £22,991 was received after the year end. There was no interest charged during the year.
During the year Optibiotix Limited transactions with Probiotix Limited were as follows:
• £440,663 for salaries and administration costs;
• £60,676 income received on behalf of Probiotix limited; and
• £544,177 repayments received.
There was no interest charged during the year. The remaining balance of £30,146 was received after the year end.
hopefully 2023 will be clearer with g myers on board - though no doubt he had input into slides - and there has been some confusion over those - my belief in him has taken a slight hit albeit only slight until 2023 accounts release
for further info see notes 4 and 18 in undernoted
https://probiotixhealth-ir.com/docs/probiotixhealthlibraries/archive/reports/ar2022.pdf
mol
Started: mol42, 1 Jun 2024 18:19
Last post: mol42, 1 Jun 2024 18:19
Https://senecavct.co.uk/wp-content/uploads/2024/03/Seneca-VCT-Investor-Presentation-May-2024-FINAL.pdf
Optibiotix
£336k B share pool investment alongside £214k Seneca EIS investment
AIM quoted investments
Reinvestment following a successful full exit in 2023 from
the B share pool – £378k at a 1.4x return
mol
Apologies slide c 35 mins gives forecast
mol
C6 hrs ago
We are delighted to have recently signed a new partnership agreement with Morepen for SlimBiome®!
‘We are pleased to announce this agreement with Morepen, a well-known and trusted supplier to pharmacies, physicians, and retail customers across India.
Morepen brings an extensive sales team with experience of highly differentiated scientific products and countrywide access to a network of around 500,000 pharmacies across India.
Based on current forecasts, the Directors anticipate this agreement could contribute in the region of £6-7 million revenue per annum in the next four to five years.’ – Stephen O’Hara, CEO of OptiBiotix
Let's wait and see what it actually generates in 2nd half 2024 and 1st half 2025 - mind we won't know former until probably this time next year (no rodders pun intended) and the latter probably not until full year 2025 disclosed ie circa may 2026
unless of course an indication given prior
i'm sure the forecasts didn't start from 4-5 years time
mol
Started: lordloadsoflolly, 20 May 2024 15:09
Last post: eshaitan, 22 May 2024 09:22
i thought i read or listened on ************* somewhere he was confident of meeting the targets but we will see. they usually disappoint to the downside.
And well below c 1.75m forecast from may 2023 slides
mol
If so aquae considering
Strong first half of trading with sales of £351k (2022: £119k), a 195% increase over H1 2022. Given H1 2022 included £19.5k from Probiotic sales up to March 30 2022, the 'like for like' increase is 251%. 85% of this sales income was received in Q2 2023
and
“The aim for the second half of the year is to maintain our focus on managing costs, growing sales and closing out ongoing discussions with a number of larger partners across first and second-generation products to ensure a return on investment from the expansion of our commercial and business development teams. We are particularly excited about our second-generation products approaching commercialisation given their uniqueness in the marketplace. Our sweet prebiotic fibres, called SweetBiotix® create the opportunity to replace unhealthy calorific and cariogenic sugars with healthy fibres in a wide range of food and beverage products. With growing health concerns over traditional sugars and sweeteners, the commercialisation of SweetBiotix® meets a large global market need. After many years of hard work we are equally pleased at the significant progress we have made in 2023 in the manufacturing scale up our microbiome modulators which selectively enhance the growth rate of specific types of bacteria and create the potential for targeted treatment of a range of human diseases. We believe these unique products, individually and collectively, offer shareholders the potential for a significant enhancement in the value of the Company.
very disappointing outturn for 2023
albeit unfortunately i don't think your forecast figure is too far out
i really hope we are both wrong - not long to wait
mol
After opti being one of the most best performing shares on aim in 2023 - a fact Stephen but basically a calculating and selective statement disregarding the past
we had
PBX - must be one of the most undervalued shares on any market
jees really Stephen - twas yourself who listed same on probably the most illiquid market to save money apparently
and then at end of presentation you pushed any questions on PBX to either the company CEO or Walbrook which neatly
sidestepped any conversation regarding your previous comments re relisting on PBX on AIM albeit our
44% subsidiary with you on the Board of same - i take that as meaning any relisting not coming anytime soon
mind i also look forward with interest regarding the 100% owned subsidiary of pbx as undernoted
Probiotix Health Denmark ApS
As formed after year end no mention as a 100% subsidiary within our 31 dec 2022 financial statements
https://ownr-dk.translate.goog/companies/public-profile/43827774?_x_tr_sl=da&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc
but presumably will be noted in our 2023 financial statements as a 100% subsidiary of our 44% interest
as to what the relevance its purpose has to probiotics or anything else to do with our 44% interest i'm at a loss
The purpose of the company
The company's purpose is to offer consultancy services linked to digital learning solutions and to sell digital learning platforms.
Number of employees
4 Employees (4 full-time, February 2024)
Steen the only Director
just a few observations on presentation
mol
I submitted a question during the presentation about Coca Cola’s logo suddenly appearing on one of the slides.
But like both my other questions, it was ignored.
If anyone can shed any further light on this, I’d be grateful.
It potentially feels significant. But as someone already posted, it could just be SOH stringing us along, despite knowing the discussions came to nowt.
Started: AustinTexas, 20 May 2024 21:57
Last post: lordloadsoflolly, 21 May 2024 11:16
Thanks AustinTexas.
By reintroducing the logo into yesterday's presentation, I guess we can assume all is not yet lost with Coca Cola.
Any reformulation would always be tested on a very small scale first, as the brand's way too valuable to risk reputational damage. Back in the 80s, Coca Cola launched "New Coke", only to have to abandon it months later & reintroduce the original formula under "Coca Cola Classic". They won't want to make the same mistake twice.
Not sure how they'd overcome the cloudiness issue though.
Coke was first mentioned about two years ago maybe longer, it’s not new news. SOH mentioned at the time that by adding Opti’s formula it made it cloudy. Also Coke are likely to launch the product on small scale to see how it’s received.
Started: elrico, 19 May 2024 11:05
Last post: elrico, 19 May 2024 11:05
OPTIBIOTIX HEALTH PLC will be holding the meeting Commercial update tomorrow at 20th May 2024 at 2:00pm BST.
Started: eshaitan, 18 May 2024 20:45
Last post: gibsonj45, 19 May 2024 11:02
Because as a seedcorn fund their policy is to withdraw funding after the early stages whatever in order to move funds to new early stage companies; the policy over-rides the financial considerations.
I’d be as interested to know why Finance Yorkshire Seedcorn Fund is selling down its position, when Opti’s share price is currently so depressed anyway.
But I guess SOH may not know that. Or want to reveal it even if he does….
Change of plan, asking this one, which I think was brought up in a bearcast some time ago
There is a share overhang caused by Finance Yorkshire Seedcorn Fund selling down their position. Why is Optibiotix's broker not finding someone to take this stock, remove the overhang and increase the share price?
I just watched last year's presentation to refresh my memory. Steve O Hara is certainly very thorough so no questions for me this time.
It will be interesting to see if 2024 forecasts are upgraded to reflect the new Indian deal signed.
Started: mol42, 16 May 2024 13:25
Last post: Bk2011, 17 May 2024 09:37
The description has been updated-
SnackSmart Slimbiome Indulgence Chocolate Peanut Bar - Prebiotic, Good for Gut Health, High Protein, Low Sugar - 12 Bars x 35g
I would think it is for a box of 10 or 12 but being Opti not clear from upload and not from any further doodling i have been doing in the last 5 mins or so
wish they would get it right from the offset - not that difficult Shiraz
mol
£25 a bar seems a bit expensive
Chocolate peanut bar
https://optibiotix.online/collections/snack-healthy/products/snacksmart-indulgence-bar
Uploaded c15 hours ago I think though slimbiome medical still prominent throughout on this one
mol
Started: mol42, 30 Apr 2024 19:11
Last post: FriedmanSowell, 17 May 2024 07:19
I think it's poor form that they haven't even booked and publicised a date for this year. The later they leave it, the harder it is for investors with commitment to make the time to be present. A cynical person might say that that's the point.
A plc must hold a general meeting (which can be deemed an agm) within 6 months of its year end
albeit opti have only managed this once in the last 5 years
26/07/23
26/07/22
09/07/21
09/07/20
11/06/19
mol
Hi Andrew7
You just need to register a free account with www.investormeetcompany.com
Once done, select Optibiotix from the company list & you'll be given the option to submit questions.
Let me know if any probs.
Hi Lord
Where does one go to submit questions for the presentation?
Https://www.optibiotix-ir.com/content/investors/financial-calendar
With this in mind, I thought about looking for when the AGM is. I've never been to one but his ability to pick and choose questions for the presentation made me think that perhaps a robust attendance from shareholders would help let him know where feelings and thoughts lie.
SOH has always leaned heavily on the claim that he builds businesses, and as such isn't focused on the share price. That was fair enough at the time but 10 years down the line, we are way beyond being a start up and should be holding our own now and enjoying the fruits of our patience.
When I looked at our Financial Calendar above though, there are no dates for 2024 on it. This seems odd. Shouldn't there be a date for the AGM now or at least some dates for 2024?
Started: mol42, 11 May 2024 18:25
Last post: mol42, 11 May 2024 19:26
Https://optibiotix.online/products/slimbiomex3
a recent addition - albeit if you scroll down slimbiome medical continues to make an appearance
won't be long though that it will disappear - i have the power
lol
mol
28 June 2023
Slimbiome Medical online sales growth
Since the end of 2022 through to April 2023 we have focused more on promoting SlimBiome® Medical as a unique product which reduces hunger and cravings which can be used as part of any calorie restriction weight management
plan. This has led to rapid growth with the ecommerce business reaching operational profitability in April and May 2023 with the highest monthly sales on record and a sales increase of 1,200%
Our medical device registration for SlimBiome® Medical runs out in May 2024. Brexit has added complexity and additional cost in reregistering a CE mark medical device with a £100k cost to renew the registration and an annual maintenance cost of £20-30K per annum per device (unflavoured and flavoured SlimBiome Medical). Given the CE mark is only applicable in Europe and we have similar products non CE marked in India and the Gulf states we are seeing this as an opportunity to rebrand and broaden the offering with different flavours to a wider customer group who may be dissuaded from purchasing a product with a medical connotation.
27 Sept 2023
The listing of SlimBiome® Medical and Gofigure® products on Amazon UK in February 2023, and Slimbiome® Medical on Amazon Germany and Walmart USA in May 2023. We anticipate further international listings on Amazon throughout 2023 including Amazon India, the Gulf States, and Amazon USA. This is all part of a strategy to increase the internationalisation of our own brand products online in 2023
01 Nov 2023
Slimbiome® Medical is consistently in the top best sellers for anti-appetite-suppressant products and achieved its highest sales in online history during Prime month in July 2023 of just over £13k. (me - wow!)
and I don't believe a mention since - I stand to be corrected
anyway still heavily promoted on our online shop - though i suppose as we are no longer in Europe perhaps it still applies in UK after May 2024
nah i really don't think so - just more obfuscation from opti
mol
Just a bit of info
Experience
OptiBiotix Health Plc
4 years 10 months
Business Development Manager
Current Apr 2020 - Present 4 years 2 months
Sales Operations Executive
Apr 2019 - Aug 2021 2 years 1 month
ProBiotix Health
2 years 1 month
Business Development Manager
Feb 2024 - Present 4 months
Head of Supply Chain
May 2022 - Feb 2024 1 year 10 months
No info re salary but obviously a related party and said info should be available to us - imo
but not presumably under current legislation
legislation AIM lol
mol
Started: Sambaqueen01, 11 May 2024 06:18
Last post: lordloadsoflolly, 11 May 2024 09:53
Problem is, the PBX “dividend” payment plummeted in value the moment the lock in period ended & shareholders were first able to sell.
AQSE is a totally illiquid & thoroughly useless exchange. SOH thought he was being clever, choosing a cheaper option than AIM. However, as is often the case, things are cheap for a reason and this “money-saving” initiative has cost us all dear. The sooner SOH follows through on his promise to review where PBX is listed, the better.
AQSE:PBX.
ProBiotix admitted to AQSE in 2022. As an OPTI holder you were entitled to benefit with what was described as a dividend. They can be traded now and should be on your broker/investment platform account. No all platforms handle AQSE shares
Good morning!
Can anyone explain what the proBiotix units actually are? Can I sell them? I’m confused 🫤 Sorry if I’m being dumb!
Started: mol42, 9 May 2024 19:12
Last post: mol42, 9 May 2024 19:12
Remember them?
well perhaps a bit of good news - albeit the travel budget perhaps took a hit if photos are contemporaneous
https://www.linkedin.com/posts/rohit-noronha-5888b115_weightmanagement-nutraceuticals-functionalfoods-activity-7185556319360225281-G1Qt?trk=public_profile
mol